SCHEMBL19851097

SCHEMBL19851097

CC(Sc1nc2cccnc2n1-c1cccc2ccccc12)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.52
SLC22A12 Q96S37 2/20 0.52
CYP2C19 P33261 1/20 0.52
PTGS2 P35354 1/20 0.51
CYP3A4 P08684 2/20 0.49
ALDH1A1 P00352 7/20 0.44
RXFP1 Q9HBX9 3/20 0.43
PRNP P04156 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPK1 P28482 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK10 P53779 1/20 0.43
HPGD P15428 3/20 0.42
CYP1A2 P05177 1/20 0.42
TSHR P16473 2/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 1/20 0.42
RECQL P46063 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851096 0.88 TSHR (0.56) CYP2C9CYP3A4ALDH1A1PRNPNPSR1
SCHEMBL21094240 0.86 ALDH1A1 (0.43) CYP2C9SLC22A12CYP2C19CYP3A4ALDH1A1
SCHEMBL23954456 0.85 ALDH1A1 (0.47) CYP2C9SLC22A12CYP2C19PTGS2CYP3A4
SCHEMBL19851020 0.85 SLC22A12 (0.74) CYP2C9SLC22A12CYP2C19PTGS2CYP3A4
SCHEMBL19851109 0.84 ALDH1A1 (0.40) CYP2C9SLC22A12CYP2C19CYP3A4ALDH1A1
SCHEMBL19851161 0.83 ALDH1A1 (0.39) CYP2C9SLC22A12CYP2C19CYP3A4ALDH1A1
SCHEMBL19851098 0.80 SLC22A12 (0.54) CYP2C9SLC22A12CYP3A4ALDH1A1MAPK1
SCHEMBL19851103 0.80 ALDH1A1 (0.53) CYP2C9CYP3A4ALDH1A1MAPK1KDM4E
SCHEMBL21093621 0.77 ALDH1A1 (0.49) CYP2C9CYP3A4ALDH1A1MAPK1HPGD
SCHEMBL19851108 0.77 ALDH1A1 (0.40) CYP2C9SLC22A12CYP3A4ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495362-B1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF UNIV SHANDONG (CN) 2021-10-27 EP disclosed
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SHANDONG UNIVERSITY (CN) 2019-09-03 US disclosed
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SHANDONG UNIVERSITY (CN) 2019-07-25 US disclosed
EP-3495362-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shandong University (CN) 2019-06-12 EP disclosed
WO-2018023851-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 山东大学 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SLC29A1, SLC28A1, SLC5A1 CYP2C9 292/4885SLC22A12 118/4885CYP2C19 1044/4885
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SLC29A1, SLC28A1, SLC5A1 CYP2C9 254/4885SLC22A12 163/4885CYP2C19 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.